6-methyl-3-(2H-1,2,3-triazol-2-yl)picolinic acid → ((2S,3R)-2-(Aminomethyl)-3-methylpiperidin-1-yl)(6-methyl-3-(2H-1,2,3-triazol-2-yl)pyridin-2-yl)methanone

Beteiligte Stoffe

Rolle	Name	HCID	Einwaage
Edukt	6-methyl-3-(2H-1,2,3-triazol-2-yl)picolinic acid	HCID 59363733	—
Edukt	((2S,3R)-2-(Aminomethyl)-3-methylpiperidin-1-yl)(5-methyl-2-(1-methyl-1H-pyrazol-4-yl)phenyl)methanone	HCID 117728145	—
Produkt	((2S,3R)-2-(Aminomethyl)-3-methylpiperidin-1-yl)(6-methyl-3-(2H-1,2,3-triazol-2-yl)pyridin-2-yl)methanone	HCID 117727634	—

Reaktionsschritte

The title compound was prepared following the same general protocol as described for ((2S,3R)-2-(aminomethyl)-3-methylpiperidin-1-yl)(5-methyl-2-(1-methyl-1H-pyrazol-4-yl)phenyl)methanone in Example A1, using 6-methyl-3-(2H-1,2,3-triazol-2-yl)picolinic acid. ESI-MS (m/z): 315 [M+1]+.

Herkunft & Nachweise

DOI	10.6084/m9.figshare.5104873.v1
Patentnummer	US09440982B2
Quelldatensatz	uspto-grants-2016_09
ORD ID	ord-0d79228c907c4ec0bc67c132345698aa
Quellennotiz	uspto-grants-2016_09